KEYTRUDA 25 mg/ml
$5,999.00
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 - 5 | — | $5,999.00 |
| 6 - 10 | 0.17 % | $5,989.00 |
| 11 - 20 | 0.33 % | $5,979.00 |
| 21+ | 0.5 % | $5,969.00 |
KEYTRUDA 25 mg powder for concentrate for solution for infusion x 1 unit
pembrolizumab (pembrolizumab)
KEYTRUDA contains the active substance pembrolizumab, which is a monoclonal antibody that works by helping your immune system fight cancer.
KEYTRUDA is used in adults to treat:
- a type of skin cancer called melanoma
- a type of lung cancer called non-small cell lung cancer.
KEYTRUDA is used in patients whose cancer has spread or cannot be removed by surgery.
You should not be given KEYTRUDA
- if you are allergic to pembrolizumab or any of the other ingredients of this medicine (listed in section 6 “Contents of the pack and other information”). Talk to your doctor if you are not sure.




